✨ Free AI Report
Henry Schein, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Henry Schein, Inc.
Company Research

Henry Schein, Inc.: Business Overview, Financials & Competitive Analysis

Henry Schein, Inc. scores 7/10 on the AskCyborg Cyborg Score (Strong). Strong cash generation and strategic pivot toward high-margin segments position Henry Schein for mid-to-high single-digit earnings growth under new leadership. In 2024, Henry Schein generated $848 million in operating cash flow, a substantial increase of $348 million from the prior year. The company reported a 3-year revenue growth rate.

What is Henry Schein, Inc.'s industry? Henry Schein, Inc. (henryschein.com) operates in Healthcare Distribution & Medical Supplies. AskCyborg classifies Henry Schein, Inc. under Healthcare Distribution & Medical Supplies in its company registry.

Henry Schein is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. With a market capitalization of $9.1 billion, the company is positio...

7/ 10Strong

Cyborg Score thesis

Strong cash generation and strategic pivot toward high-margin segments position Henry Schein for mid-to-high single-digit...

Read the full analyst-debate transcript →
Industry Healthcare Distribution & Medical Supplies
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Henry Schein, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Henry Schein, Inc.

AskCyborg analysts argue the bull and bear cases for Henry Schein, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Henry Schein, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Henry Schein, Inc. Overview

Pro stress-test →

Henry Schein is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. With a market capitalization of $9.1 billion, the company is positioned within the healthcare sector, specifically in the medical distribution industry. The company serves over 1 million customers globally with a portfolio exceeding 300,000 products.

Strategic Profile

Pro stress-test →

The company's updated 2025 to 2027 BOLD+1 Strategic Plan aims to achieve high-single-digit to low-double-digit earnings growth, underpinned by a deliberate shift toward higher-margin businesses. Henry Schein exceeded its 2024 goal of generating 40% of its worldwide operating income from high-growth, high-margin businesses, with an ambitious target to increase this to 50% by the end of 2027.

Competitive Landscape

Pro stress-test →

Henry Schein competes in the medical/dental distribution market against companies including McKesson (broader medical distribution), Medline Industries (medical devices and supplies), and Patterson Companies (dental equipment and supplies). The company differentiates through its global scale, integrated technology platform, specialty products portfolio, and value-added services to dental and medical practitioners.

Industry Context

Henry Schein, Inc. operates in Healthcare Distribution & Medical Supplies.

Key facts

Founded: 1932 · Headquarters: Melville, US · Revenue: $12.94B · Market cap: $9.1B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Henry Schein, Inc..

  • Frederick Lowery appointed as new CEO, effective March 2, 2026, taking over from Stanley Bergman after 35 years.
  • Global Specialty Products group is driving higher growth, while Global Technology segment expands at a more modest pace.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026New CEO Frederick Lowery takes helm as leadership transition begins
  • January 2026CytoChip partnership announced for exclusive distribution of CitoCBC diagnostic system
  • +1 moreTrack every material event for Henry Schein, Inc. as it happens. Explore monitoring →
Get alerted when Henry Schein, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

McKessonBroadline pharmaceutical and medical supply distributor→MedlineMedical devices and supplies distributor→PattersonDental equipment and medical supplies distributor→

Compare Henry Schein, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Henry Schein, Inc. operates in Healthcare Distribution & Medical Supplies. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare Distribution & Medical Supplies research →
NEW · MCP server

Ask your AI assistant about Henry Schein, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Henry Schein, Inc. and its top competitor on Cyborg Score”
“What did Henry Schein, Inc. do this quarter?”
“Is Henry Schein, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Henry Schein, Inc. do?+
Henry Schein is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. With a market capitalization of $9.1 billion, the company is positio...
What is Henry Schein, Inc.'s Cyborg Score?+
Henry Schein, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Henry Schein, Inc.'s main competitors?+
Named competitors include McKesson, Medline, Patterson. The full competitive landscape is in the AskCyborg report.
How can I get the full Henry Schein, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Henry Schein, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Henry Schein, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Healthcare Distribution & Medical Supplies research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8McKesson Corporation8Medline Inc.